1. Introduction {#s0005}
===============

Human resources are an integral part of every healthcare system [@b0005]. However, in low- and middle-income countries (LMICs), human resources for health (HRH) are often limited, which impacts both the access to and quality of healthcare [@b0005], [@b0010]. The shortage of healthcare workers can be due to different factors such as low production capacity for HRH, brain drain of healthcare workers, inefficient use of human resources or imbalance in the composition of demographics [@b0015], [@b0020]. As the demand for healthcare services increases, this scarcity can result in instability of the healthcare system. In addition, introducing health interventions or technologies will always have an effect on the demand for human resources and this should be a serious concern for decision-makers, especially in LMICs, as training health workforce (i.e. general practitioners and medical specialists) requires a considerable amount of time [@b0025], [@b0030], [@b0035].

Vaccination can be considered as a unique intervention in the context of human resources. Vaccination programs are a long-term investment for preventing specific diseases, and have a dynamic effect on the utilization of different types of HRH. Vaccination programs could increase the present need of particular types of human resources and reduce the future need of the health workforce in treating vaccine preventable diseases [@b0040], [@b0045]. Although there are few papers addressing the success of vaccination in terms of HRH requirements [@b0010], [@b0050], no study has been conducted that compares the impact of vaccinations in terms of both HRH needed and reduced within a study.

It would be appropriate for evidence-informed policy decisions to take into account both HRH required and saved due to vaccinations. Therefore, this study aims to take this challenge by estimating the HRH needed and reduced as a result of introducing the pneumococcal conjugate vaccine (PCV). This study is conducted as an additional analysis to the economic evaluation using the Philippines as a case study due to their existing economic model which compares various vaccination policy options [@b0055].

2. Material and methods {#s0010}
=======================

This study examines the impact of HRH by using the quantity, task, and productivity (QTP) model. The QTP model is one of the approaches to determine HRH and was developed under the concept of functional job analysis whereby the skill requirements to complete a certain task are assessed [@b0060]. There are four main key features of this model: (1) it includes a set of priority interventions, (2) it estimates HRH by calculating the number of cases needed for a service (service quantity), (3) it identifies the tasks and estimates the time needed to deliver a service, and (4) it includes the productivity by combining staff productivity and service productivity. This model has been developed for low-income countries that want to scale up their priority interventions. A study conducted by Kurowski et al. showed that the QTP method was robust in estimating the required human resources [@b0065].

Furthermore, this model is practical and feasible for application in the Philippines where data resources are restricted. The adapted version of the QTP model for estimating the HRH impact of introducing the PCV vaccination in the Philippines is shown in Supplement A. Using this model, the HRH-related parameters were obtained from existing clinical practice guidelines [@b0070], [@b0075], [@b0080], [@b0085] wherein the applicability of each procedure in the local setting was verified by conducting interviews with healthcare providers. The adapted QTP model includes four major steps ([Fig. 1](#f0005){ref-type="fig"}) and is described in the following paragraphs.

In the first step, several health services for the treatment of pneumococcal-related diseases were identified, including the number of cases that occurred in each scenario, i.e. with and without the vaccination program. The number of cases for each disease was estimated using the Markov model from a prior economic evaluation study that was conducted in the Philippines [@b0055]. One-year time horizon was employed in this study, while the prior economic evaluation used a Markov model with a lifetime horizon. The target population for universal coverage of the PCV vaccination was set at 2,200,000 eligible infants below the age of one year based on 2013 data obtained from the Philippine Statistics Authority [@b0090].

In the second step, the types of health workforces needed for each type of health service relating to vaccination, treatments of non-hospitalized pneumonia, and acute otitis media were obtained based on consensus among municipal health officers in the seminar for the primary care benefit package of the state insurance scheme; meanwhile, data on treatment of meningitis, sepsis/bacteraemia and hospitalized pneumonia in intensive care units (ICU) and non-ICUs were derived from four medical specialists. In the data collection process, participants were given information on healthcare services as stated by the clinical practice guidelines from the Philippine Health Insurance Corporation [@b0070]; Philippine Clinical Practice Guidelines on the Diagnosis, Empiric Management, and Prevention of Community-acquired Pneumonia (CAP) in Immunocompetent Adults [@b0075]; and Integrated Management of Childhood Illness (IMCI) [@b0080], [@b0085]. After that, they were asked to indicate the set of healthcare services they provide in their practice, followed by identifying the types of health workforce needed as well as the average amount of time (minutes) for each health professional spent per treated patient or vaccinated child.

In the third step, the magnitude of HRH needed for each policy option was estimated. Staff productivity was assumed to be 6 h or 360 min per day, with 220 working days in a year. The number of healthcare workers needed for the implementation of the PCV vaccination and for the treatment of pneumococcal-related diseases was calculated in full-time equivalent (FTE) using the formula below. One FTE equals one employee that works on a full-time basis. In the last step, HRH needed and reduced were compared with each other for each policy option.$$\text{Number\ of\ healthcare\ workers}\mspace{6mu}\mspace{6mu}(\text{in\ FTEs}) = \frac{\text{Total\ time\ spent\ of\ healthcare\ provider\ per\ case}\mspace{6mu}(\text{minutes}) \times \text{Number\ of\ cases\ or\ target\ population}}{\text{Total\ working\ time\ per\ year}\mspace{6mu}( = 360 \ast 220\ \text{min}/\text{person}/\text{year})}$$

3. Results {#s0015}
==========

Based on five available policy options (no vaccination program, PCV10 with 25 percent coverage, PCV10 with 100 percent coverage, PCV13 with 25 percent coverage, and PCV13 with 100 percentage coverage), [Table 1](#t0005){ref-type="table"} illustrates six types of healthcare services that are related to the prevention or treatment of pneumococcal-related diseases: vaccination, meningitis treatment, sepsis/bacteraemia treatment, hospitalized pneumonia treatment, non-hospitalized pneumonia treatment, and acute otitis media treatment. Regardless of the vaccination program, the demand for acute otitis media treatment is the highest, followed by the pneumonia treatment. Implementing the PCV10 or PCV13 would reduce the number of the aforementioned vaccine-preventable conditions. The higher the vaccination coverage, the lower the number of patients treated.

[Table 2](#t0010){ref-type="table"} presents the average amount of time that each type of health professional spends per treated patient or vaccinated child. The average time spent per case is the highest for the treatment of meningitis by paediatricians, which equals 746.50 min per case. The lowest average time spent per care is for midwives, which is only 5 min for non-hospitalized pneumonia and acute otitis media treatment, and for radiologists, which is 5 min for both hospitalized and non-hospitalized pneumonia treatment.

Further, the number of healthcare professionals needed for each policy option was identified in [Table 3](#t0015){ref-type="table"}. This table and [Fig. 2](#f0010){ref-type="fig"} show the increase and reduction of FTEs for each type of healthcare professionals required for the treatment of pneumococcal-related diseases resulting from the implementation of the PCV vaccination policy. It can be seen that the implementation of the PCV vaccination significantly increases the number of general practitioners, nurses, and midwives required for the vaccination program.

4. Discussion {#s0020}
=============

This is the first attempt to estimate the impact of HRH alongside a model-based economic evaluation study, which can be eventually applied to other studies, especially those that inform resource allocation in developing settings where not only financial resources but HRH are also constrained. This study is different from economic evaluations, which focus only on comparisons between costs and outcomes (Incremental Cost-Effectiveness Ratio; ICER). Although economic evaluation guidelines recommend reporting costs and resources used separately [@b0095], [@b0100], only few papers do this [@b0105], [@b0110] and even fewer papers report resources used by giving detailed information of health workforce. This HRH study is a complementary analysis and the results are reported as HRH saved and needed (in terms of FTE). The results showed that the number of FTEs for GPs, nurses, and midwives increases significantly if the universal vaccination coverage policy is implemented. Nevertheless, the vaccination program can avert HRH requirement for specialized healthcare professionals who require longer term training and are more restricted compared to GPs, nurses, and midwives in the Philippines [@b0115]. Moreover, the salary of GPs, nurses, and midwives are likely to be lower than those specialized healthcare professionals.

An associated cost-effectiveness analysis found that the universal coverage for PCV13 has the lowest ICER compared to no vaccination amongst the four vaccination strategies [@b0055]. Although this policy needs an additional 380 FTEs for general practitioners, 602 FTEs for nurses, and 205 FTEs for midwives, it can reduce the number of FTEs for medical social workers, paediatricians, infectious disease specialists, neurologists, anaesthesiologists, radiologists, ultrasonologists, medical technologists, radiologic technologists and pharmacists by 7, 17.9, 9.7, 0.4, 0.1, 0.7, 0.1, 12.3, 2, and 9.7, respectively, when compared to the no vaccination policy. From the analysis can also be observed that HRH requirements for both PCV10 and PCV13 were very similar, meaning that choosing PCV13 over PCV10 would not have differed in terms of HRH impact. This type of information should be presented to decision-makers so that they can make an appropriate and feasible policy choice, taking into account not only cost-effectiveness evidence and budget impact but also impact on HRH, which cannot be increased within a short period of time. Neglecting information on HRH when introducing any large health programs, including vaccination, can put the policy at high risk of failure due to the overburden of existing healthcare workers.

If the estimated HRH required seems infeasible for implementing a universal vaccination program, a proper plan for task shifting of vaccination activities -- i.e. physical examinations that are being carried out by GPs - to nurses, midwives, and pharmacists should be investigated. Meanwhile, FTEs of specialized healthcare professionals freed up by the vaccination program can be used for other health policies. In addition, it is interesting to note that only a relatively small reduction of FTEs among specialized healthcare workers from the vaccination program was observed in this study. An explanation could be that in the Philippines, there is a severely limited number of these specialists and they are working under high workloads, resulting in limited time spent for each patient treated. The prevention of pneumococcal-related diseases from the vaccination means that they can spend a longer time providing better care for patients. Although this study did not investigate whether the current time allocated to the treatment of pneumococcal-related diseases was appropriate, the current estimates indicate that the quality of care may be less than optimal due to shortages of key staff.

This study has some limitations. Firstly, the profile (type) and magnitude (time spent) of health professionals required for each service are specific to the context of the Philippines; therefore, the use of this study's results for other settings needs to be performed with caution. Secondly, the study focuses on the impact of HRH at the national level. However, the aforementioned HRH may not be distributed equally across geographical locations, especially between urban and rural areas [@b0120]. It would be necessary to estimate the HRH impact for each province when introducing the vaccination policy in order to ensure that HRH planning is adequate across sub-national levels. Thirdly, this study only considered a one-year time horizon despite the fact that previous evidence suggested that the vaccine may be able to prevent pneumococcal-related diseases for up to 5 years after vaccination [@b0125], which may result in an underestimation of HRH freed up by the vaccine program. However, this study already included herd protection for universal vaccination coverage but not for 25 percent coverage. Lastly, this study employed an expert opinion approach for data collection on the number of minutes used by health professionals in treating each child and this can be problematic in terms of robustness. Although experts were requested to discuss about the estimates among their peers in order to ensure that the provided numbers were feasible, this might not be an ideal approach. With this regard, it is recommended for future study to conduct a prospective observational data collection. The benefit of collecting primary data from observation is that a probabilistic sensitivity analysis can be performed to assess the uncertainty on parameters.

There are two interesting points for further study: 1) to explore the effects of adherence to clinical practice guidelines for physicians on estimating HRH in comparison to real practice, and 2) to consider whether there is a need for discounting if the HRH impact is estimated beyond a one-year time horizon. For example, when implementing the human papilloma virus (HPV) vaccination program at present, the effects on HRH (e.g., cervical oncologists) will occur in the next twenty or thirty years. In such case, it is questionable whether the effects on HRH in the future should be discounted similarly to the standard practice in economic evaluations that discounts further costs and outcomes [@b0095]. Furthermore, the future impact of technology and innovation will have unknown implications on the HRH required in terms of health management. Any adjustments for predicted HRH in the future may introduce considerable uncertainty and may limit future HRH planning.

5. Conclusions {#s0025}
==============

This study examines an approach for estimating HRH impact alongside economic evaluation studies on PCV vaccination policy in the Philippines. It illustrates the importance of HRH impact estimations to inform policy decisions in resource-limited settings; this is to ensure that comprehensive evidence was used to formulate policy choice for decision makers. The study informs the reduction of specialized healthcare professionals for treatment of pneumococcal-related diseases vis-a-vis the increase of HRH requirement among GPs, nurses, and midwives as a result of implementing a PCV vaccination program. The authors conclude that the HRH impact should be estimated to inform priority setting for a vaccination program.
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###### 

Number of cases receiving health care services by policy options.

  Types of health care services          Policy options                                       
  -------------------------------------- ---------------- ----------- ----------- ----------- -----------
  Vaccination                            0                550,000     2,200,000   550,000     2,200,000
  Meningitis treatment                   3331             3305        2807        3295        2747
  Sepsis/ Bacteremia treatment           3260             3247        2679        3242        2612
  Hospitalized pneumonia treatment       327,714          326,947     323,592     326,654     322,272
  Non-hospitalized pneumonia treatment   218,476          217,965     215,728     217,769     214,848
  Acute otitis media treatment           2,550,431        2,541,432   2,514,437   2,537,981   2,500,631

###### 

Average amount of time that each type of health professional spent per vaccinated child/adult[⁎](#tblfn1){ref-type="table-fn"}.

  Types of health care services          Average time spent per case (min)                                                                                 
  -------------------------------------- ----------------------------------- -------- -------- ------- ------ ---- ---- ------ ------- ------ ----- ------ -----
  Vaccination                            \-                                  15       \-       \-      \-     \-   \-   \-     \-      \-     \-    22.5   7.5
  Meningitis treatment                   82.5                                \-       746.5    562.5   58.8   15   \-   13.5   117.5   \-     315   630    \-
  17.5^∗^                                345^∗^                              195^∗^   390^∗^                                                               
                                                                                                                                                           
  Sepsis/ bacteremia treatment           90                                  \-       529      404     \-     \-   10   \-     165     8      210   420    \-
  128.8^∗^                               150^∗^                              300^∗^                                                                        
                                                                                                                                                           
  Hospitalized pneumonia treatment       82.5                                \-       300.3    237.8   \-     \-   5    \-     117.5   17.5   105   210    \-
  12.8^∗^                                75^∗^                               150^∗^                                                                        
                                                                                                                                                           
  Non-hospitalized pneumonia treatment   \-                                  72.5     \-       \-      \-     \-   5    \-     22.5    17.5   \-    37.5   5
                                                                                                                                                           
  Acute otitis media treatment           \-                                  52.5     \-       \-      \-     \-   \-   \-     \-      \-     \-    7.5    5

Treatment time of an adult.

###### 

Number of full time equivalent for each type of health care worker for each policy option.

  Types of health care worker   Policy options                              
  ----------------------------- ---------------- -------- -------- -------- --------
  Medical Social Worker         348.5            347.4    341.5    347.7    343.0
  General Practitioner          1890.6           1985.9   2271.0   1988.4   2280.9
  Pediatrician                  961.1            956.6    943.2    957.9    948.2
  IDS                           263.9            263.9    254.2    263.9    255.0
  Neurologist                   2.5              2.4      2.0      2.5      2.1
  Anesthesiologist              0.6              0.6      0.5      0.6      0.5
  Radiologist                   34.9             34.8     34.2     34.8     34.4
  Ultrasonologist               0.6              0.6      0.5      0.6      0.5
  Medical Technologist          563.3            561.5    551.0    562.0    553.5
  Radiologic Technologist       116.2            115.8    114.2    115.9    114.7
  Pharmacist                    421.9            420.3    412.2    420.7    414.2
  Nurse                         1185.9           1340.3   1787.9   1341.6   1793.7
  Midwife                       174.8            226.1    379.8    226.3    380.7
